1. X
  2. PeerView
Log inSign up
PeerView
21.9K posts
Image
user avatar
PeerView
@PeerView
Improving the knowledge, skills, and strategies that support clinical performance and patient outcomes through the provision of live and on-demand CE
New York, NY
ww2.peerview.com
Joined June 2009
4,867
Following
5,393
Followers
RepliesRepliesMediaMedia

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
  • user avatar
    PeerView
    @PeerView
    Apr 30, 2025
    Join @PeerView at #ASCO25 for a powerhouse lineup of #oncology symposia covering #HCC, #NSCLC, #CRC, #MM, #AML, #gastriccancer & more. Don’t miss expert insights, cases & #CME credits—live in Chicago or virtually! Register now ⏩ bit.ly/Onc25T Proud to partner &
    peerview.com
    PeerView
    MDADI
    3.9K03.9K
  • user avatar
    PeerView
    @PeerView
    Nov 17, 2023
    Watch Steven Brem, MD, Manmeet S. Ahluwalia, MD, MBA, FASCO, and Michelle Kim, MD, discuss #Glioblastoma updates from #SNO2023 - to participate, visit: bit.ly/2023GBMT x.com/i/broadcasts/1…
    peerview.com
    PeerView
    MDADI
    10K010K
  • user avatar
    PeerView
    @PeerView
    Nov 3, 2023
    Newly posted! Check out our practice aids on #AML from our recently released activity from #SOHO2023. Featuring @Daver_Leukemia & Gail J. Roboz, MD bit.ly/46wsMil #MedEd #MedTwitter
    Image
    3.6K03.6K
  • user avatar
    PeerView
    @PeerView
    Jan 7, 2025
    EGFR-mutated advanced #NSCLC requires a personalized approach. Experts @StephenVLiu and @ZpiotrowskaMD share case-based insights to enhance your care plans. Don’t miss the on-demand recorded at #MaTOS2024!
    Image
    Refining the First Strike Against EGFR-Mutated Advanced NSCLC: Personalizing Frontline Treatment...
    From lrn.peerview.com
    2.3K02.3K
  • user avatar
    PeerView
    @PeerView
    Jul 13, 2022
    Drs. Choueiri (@DrChoueiri), Pal (@montypal), and Zhang (@TiansterZhang) discuss novel therapies for advanced #RCC, including TKIs, immune checkpoint inhibitors, and combinations in this #CME activity based on an event at #ASCO22 and produced with @kcCURE bit.ly/3vtCeRS
  • user avatar
    PeerView
    @PeerView
    Jun 9, 2023
    What are the pros/cons of neoadjuvant, adjuvant, or combined strategies of perioperative #Immunotherapy in #NSCLC? Find out from @DoctorJSpicer, @sara_najmeh, and @paugalde20 in this educational activity from #AATS2023 bit.ly/40AkhiU
    8.8K08.8K
  • user avatar
    PeerView
    @PeerView
    Apr 15, 2018
    Prof. Solange Peters (@peters_solange) explains how to test for TMB at #PeerView #AACR18 #immunooncology symposium bit.ly/Cancer-18
    Image
  • user avatar
    PeerView
    @PeerView
    Apr 4, 2023
    Better navigate the new evidence and incorporate perioperative #Immunotherapy in modern management of #NSCLC, including neoadjuvant and adjuvant approaches, by watching @DoctorJSpicer & @AltorkiNasser in this new #MedEd video from #STS2023 #LungCancer bit.ly/3TQE0qe
    3.2K03.2K
  • user avatar
    PeerView
    @PeerView
    Apr 15, 2018
    Dr. Omid Hamid (@OmidHamidMD) explores new #cancer #immunotherapy targets and combinations under investigation at #PeerView #AACR18 symposium bit.ly/Cancer-18
    Image
  • user avatar
    PeerView
    @PeerView
    Dec 4, 2023
    Get the latest evidence for #AntibodyDrugConjugates in #SolidTumors from an expert panel: bit.ly/44pdnhX #MedTwitter #MedEd #OncTwitter #Oncology #ESMO23 #WCLC23 @PTarantinoMD @erikahamilton9 @APassaroMD @YJanjigianMD
    Image
    2.7K02.7K
  • user avatar
    PeerView
    @PeerView
    Jan 11, 2024
    Register ASAP for this January 18th #BiliaryCancer #MedEd Symposium at 5:15 PM PST during #GI24! With Drs. Milind Javle (@JavleMilind), Tanios Bekaii-Saab (@GIcancerdoc) & Rachna Shroff (@rachnatshroff) & developed with @curecc! bit.ly/BiliarySF24T #Oncology #MedTwitter
    Image
    1.3K01.3K
  • user avatar
    PeerView
    @PeerView
    May 31, 2025
    Thank you to @Daver_Leukemia, @jaltmanmd, and Dr. Alice Mims for leading an engaging @PeerView x @HealthTree #AML symposium at #ASCO25! If you missed the live session, stay tuned for the replay. bit.ly/AML-T
    Image
    1.3K01.3K
  • user avatar
    PeerView
    @PeerView
    Jul 19, 2021
    If you are involved in #LungCancer care, you will want to watch our newest CME/MOC/CC/NCPD video. Hear from the experts, led by Stephen V. Liu, MD (@StephenVLiu) who discuss the biomarker testing and targeted therapies in NSCLC. bit.ly/3dUOUbN #LCSM @LUNGevity
  • user avatar
    PeerView
    @PeerView
    Dec 8, 2017
    Dr. Harry Erba opening with a groundbreaking year for new approvals in #AML #ASH17 #PeerView bit.ly/AMLI7
    Image
Advertisement
Advertisement